Stockscreener 앱 받기
0.6544
0.93%
0.006
시간 외 거래:
.64
-0.0144
-2.20%
Envoy Medical Inc 주식(COCH)의 최신 뉴스
Envoy Medical Inc. (COCH) Q1 2026 Earnings: EPS Surprise Beats Estimates, but Stock Declines Amid Missing RevenueGuidance Upgrade Report - newsline.com
Envoy Medical, Inc. Class A Financial Disclosures & SEC Filings - TradingView
Envoy Medical (COCH) registers 15.12M shares from warrants, $20.1M if cashed - Stock Titan
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA - ACCESS Newswire
New to The Street Broadcasting Saturday June 13th 630pm Est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA - Moomoo
COCH Q1 2026 Earnings: Narrower Loss Beats EstimatesBanking Earnings Report - newsline.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Envoy Medical Inc. (COCH) Q1 2026 Earnings: EPS Surprises to the Upside, Revenue Not ReportedEarnings Beat Alert - newsline.com
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET - newswire.com
Envoy Medical (COCH) Slips Over 3% as Bearish Pressure Intensifies – Support Test LoomsBollinger Expansion - newsline.com
COCH Q1 2026 Earnings: Loss Narrower Than Expected as Pre-Revenue Company Advances PipelineLow Growth Earnings - newsline.com
Envoy Medical (COCH) CEO adds ESPP shares and reports large warrant, option holdings - Stock Titan
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th - marketscreener.com
Hearing implant developer Envoy Medical heads to Vegas investor conference - Stock Titan
Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street - Black Hills Pioneer
Envoy Medical (NASDAQ: COCH) Signs Multi-Part Series With New to The Street - marketscreener.com
Envoy Medical (COCH) Holds Steady Near Support as Penny Stock Seeks DirectionIsland Reversal - newsline.com
COCH Q1 2026 Earnings: EPS Surprise Beats Estimates Amid Pre-Revenue StageEarnings Decline Risk - The Legal Advocate
Envoy Medical Inc Warrant (COCHW) Holds Steady at $0.06 Amid Minimal TradingFade Trade - newsline.com
Envoy Medical (COCH) Slips Slightly as Traders Eye Key Support at $0.66Gamma Flip Level - The Legal Advocate
Envoy Medical Inc Warrants (COCHW) Hold Steady at $0.06 as Trading Activity Remains SubduedOvernight Profile - The Legal Advocate
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - Florida Hospital News and Healthcare Report
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseLow Estimate Range - Newser
Envoy Medical Granted Extension to Regain Nasdaq Compliance - The Globe and Mail
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Progress, Though Revenue Absence Raises QuestionsHigh Growth Earnings - Newser
Envoy Medical Inc. (COCH) Q1 2026 Earnings: Strong EPS Beat Amidst Pre-Revenue StageEarnings Per Share - Newser
Envoy Medical Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue, Stock DeclinesTrading Community Hub - Newser
COCH Q1 2026 Earnings: Significant EPS Beat Amid Revenue UncertaintyElite Trading Signals - Newser
Envoy Medical Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule - Stock Titan
COCH Q1 2026 Earnings: Narrower Loss Beats Estimates as Envoy Medical AdvancesReturn On Assets - Newser
COCH Q1 2026 Earnings: EPS Beats Estimates Despite Pre-Revenue Status, Stock DeclinesShared Buy Zones - Newser
Daily Penny AlertsEnvoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - FinancialContent
4 new patents push fully implanted hearing tech at Envoy Medical - Stock Titan
Envoy Medical shareholders approve plan amendments and board elections at annual meeting By Investing.com - Investing.com South Africa
Envoy Medical shareholders approve plan amendments and board elections at annual meeting - Investing.com Australia
Envoy Medical Shareholders Expand Equity and Governance Plans - TipRanks
Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans - Stock Titan
Envoy Medical (COCH): Nantahala reports 9.99% position in company - Stock Titan
[SCHEDULE 13G] Envoy Medical, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Envoy Medical Flags Limited Risk Detail, Urges Investors to Review 2026 Form 10-K for Key Uncertainties - The Globe and Mail
TradingKey - TradingKey
Envoy Medical, Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and FDA-Approved Hearing Devices Overview - Minichart
ENVOY MEDICAL (COCH) insiders report 2.46M warrants, 3.10% stake - Stock Titan
Envoy Medical completes pivotal trial enrollment, raises $78m By Investing.com - Investing.com South Africa
Envoy Medical Achieves Pivotal Trial Milestone and Secures $78M Financing for Fully Implanted Cochlear Implant FDA Approval Progress - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m - Investing.com
Envoy Medical, Inc. 1Q 2026: Revenue $39K, Net income ($5.7M), EPS ($0.08) — 10-Q Summary - TradingView
2.43%
자본화:
|
볼륨(24시간):